The purpose of this application is to continue a training program devoted to the study of the molecular and cellular basis of cardiovascular diseases and to the development of novel therapeutic approaches to these diseases. Our proposal builds on a strong tradition of cardiovascular research and clinical training at the University of Washington School of Medicine. This renewal application is more specifically focused on four areas of opportunity with the broader field of cardiovascular disease research: (1) Signaling and Vascular Injury;(2) Gene and Cell Therapy;(3) Genetics of Cardiovascular Risk;and (4) Biomechanics, Bioengineering, and Cardiovascular Imaging. These are all areas of established strength at the University of Washington School of Medicine. This program is the major source of support for clinical fellows in Cardiology, Cardiovascular Pathology, and Vascular and Cardiothoracic Surgery who wish to spend a substantial portion of their training time acquiring the skills that are required to succeed as independent, laboratory-based principal investigators. The program also provides support for trainees with Ph.D. degrees who wish to pursue training in laboratories that have a significant focus on molecular and cellular biology and genetics of the mammalian cardiovascular system.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007828-15
Application #
8081023
Study Section
Special Emphasis Panel (ZHL1-CSR-J (F1))
Program Officer
Roltsch, Mark
Project Start
1997-07-01
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
15
Fiscal Year
2011
Total Cost
$322,867
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Guo, Xiaoyun; Yin, Haifeng; Li, Lei et al. (2017) Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis. Circulation 136:729-742
Ronsein, Graziella E; Heinecke, Jay W (2017) Time to ditch HDL-C as a measure of HDL function? Curr Opin Lipidol 28:414-418
Long, Matthew E; Eddy, William E; Gong, Ke-Qin et al. (2017) MEK1/2 Inhibition Promotes Macrophage Reparative Properties. J Immunol 198:862-872
Wallingford, Mary Catherine; Chia, Jia Jun; Leaf, Elizabeth M et al. (2017) SLC20A2 Deficiency in Mice Leads to Elevated Phosphate Levels in Cerbrospinal Fluid and Glymphatic Pathway-Associated Arteriolar Calcification, and Recapitulates Human Idiopathic Basal Ganglia Calcification. Brain Pathol 27:64-76
Gasperini, Molly; Findlay, Gregory M; McKenna, Aaron et al. (2017) CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions. Am J Hum Genet 101:192-205
Angelov, Stoyan N; Zhu, Jay; Dichek, David A (2017) New Mouse Model of Abdominal Aortic Aneurysm: Put Out to Expand. Arterioscler Thromb Vasc Biol 37:1990-1993
Wall, Valerie Z; Barnhart, Shelley; Kramer, Farah et al. (2017) Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (?C20)-acyl chains in macrophages. J Lipid Res 58:1174-1185
Angelov, Stoyan N; Zhu, Jay; Hu, Jie Hong et al. (2017) What's the Skinny on Elastin Deficiency and Supravalvular Aortic Stenosis? Arterioscler Thromb Vasc Biol 37:740-742
Pamir, Nathalie; Hutchins, Patrick M; Ronsein, Graziella E et al. (2017) Plasminogen promotes cholesterol efflux by the ABCA1 pathway. JCI Insight 2:
Angelov, Stoyan N; Hu, Jie Hong; Wei, Hao et al. (2017) TGF-? (Transforming Growth Factor-?) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms. Arterioscler Thromb Vasc Biol 37:2102-2113

Showing the most recent 10 out of 140 publications